Coeptis Therapeutics, Inc. Operating Income
Coeptis Therapeutics, Inc. reported Operating Income of -$5.57 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-08.
Discontinued › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2022-11-08
- Coeptis Therapeutics, Inc. operating income (loss) for the quarter ending 2022-09-30 was -$5.57M.
- Coeptis Therapeutics, Inc. operating income (loss) for the quarter ending 2022-06-30 was -$9.81M.
- Coeptis Therapeutics, Inc. operating income (loss) for the quarter ending 2022-03-31 was -$15.77M.
- Coeptis Therapeutics, Inc. operating income (loss) for the quarter ending 2021-12-31 was -$2.96M.
- Coeptis Therapeutics, Inc. operating income (loss) for fiscal 2021 was -$14.23M.
- Coeptis Therapeutics, Inc. operating income (loss) for fiscal 2020 was -$6.86M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 3 month as first filed | Operating Income (Loss) 4 month | Operating Income (Loss) 6 month | Operating Income (Loss) 7 month | Operating Income (Loss) 8 month | Operating Income (Loss) 9 month | Operating Income (Loss) 10 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|---|---|---|---|---|
| 2022-09-30 | -$5.57M 10-Q · filed 2022-11-08 | -$15.38M derived: sum of 2 quarters · filed 2022-11-08 | -$31.15M 10-Q · filed 2022-11-08 | -$34.11M derived: sum of 4 quarters · filed 2022-11-08 | |||||
| 2022-06-30 | -$9.81M 10-Q · filed 2022-08-02 | -$25.58M 10-Q · filed 2022-08-02 | -$28.55M derived: sum of 3 quarters · filed 2022-08-02 | -$35.49M derived: sum of 4 quarters · filed 2022-11-08 | |||||
| 2022-03-31 | -$15.77M 10-Q · filed 2022-05-12 | -$18.73M derived: sum of 2 quarters · filed 2022-05-12 | -$25.68M derived: sum of 3 quarters · filed 2022-11-08 | -$28.30M derived: sum of 4 quarters · filed 2022-11-08 | |||||
| 2021-12-31 | -$2.96M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$9.91M derived: sum of 2 quarters · filed 2022-11-08 | -$12.53M derived: sum of 3 quarters · filed 2022-11-08 | -$14.23M 10-K · filed 2022-03-11 | |||||
| 2021-09-30 | -$6.95M 10-Q · filed 2022-11-08 | -$9.57M derived: sum of 2 quarters · filed 2022-11-08 | -$11.27M 10-Q · filed 2022-11-08 | -$15.46M derived: sum of 4 quarters · filed 2022-11-08 | |||||
| 2021-06-30 | -$2.62M 10-Q · filed 2022-08-02 | -$2.62M 10-Q · filed 2021-08-16 | -$4.32M 10-Q · filed 2022-08-02 | -$8.51M derived: sum of 3 quarters · filed 2022-08-02 | |||||
| 2021-03-31 | -$1.70M 10-Q · filed 2022-05-12 | -$5.88M derived: sum of 2 quarters · filed 2022-05-12 | |||||||
| 2020-12-31 | -$4.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | -$566.68K 10-KT · filed 2021-05-11 | -$6.86M 10-K · filed 2022-03-11 | ||||||
| 2020-11-30 | -$487.37K 10-Q · filed 2021-01-11 | -$508.11K 10-Q · filed 2021-01-11 | |||||||
| 2020-09-30 | -$1.61M 10-Q · filed 2021-11-15 | -$2.68M 10-Q · filed 2021-11-15 | |||||||
| 2020-08-31 | -$12.12K 10-Q/A · filed 2020-11-23 | -$20.74K 10-Q/A · filed 2020-11-23 | |||||||
| 2020-06-30 | -$687.24K 10-Q · filed 2021-08-16 | -$1.07M 10-Q · filed 2021-08-16 | |||||||
| 2020-03-31 | -$396.40K 10-Q/A · filed 2021-05-18 | ||||||||
| 2019-12-31 | -$99.00 10-KT · filed 2021-05-11 | ||||||||
| 2019-11-30 | $0.00 10-Q · filed 2021-01-11 | $0.00 derived: sum of 2 quarters · filed 2021-01-11 | -$99.00 10-Q · filed 2021-01-11 | ||||||
| 2019-08-31 | $0.00 10-Q/A · filed 2020-11-23 | -$99.00 10-Q/A · filed 2020-11-23 |